Stock market crash: UK shares that I think are too cheap to ignore

Even months after the stock market crash there are still opportunities to pick up cheap shares, says Andy Ross.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

sdf

The recovery from this year’s earlier stock market crash has been a slow process for most shares. Now even US tech shares are falling. Closer to home, I think the crash means there are UK shares that are very cheap.

Lagging behind its rivals but with potential 

One is the big pharma group GlaxoSmithKline (LSE: GSK), which is involved in finding a vaccine for Covid-19. For me that’s not the reason to invest though. I find the possibility of a R&D-led turnaround, and the potential that has to make GlaxoSmithKline a high-yielding, dividend growth share, to be very appealing.

Progress towards on path has been slower than some may like. Rival AstraZeneca is much further ahead. But under CEO Emma Walmsley, it’s progressing. The group will spin out its consumer healthcare business within the next three years. It has also spent money on acquiring TESARO, for example, to beef up its oncology portfolio.

Should you invest £1,000 in Ashtead Group Plc right now?

When investing expert Mark Rogers has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for nearly a decade has provided thousands of paying members with top stock recommendations from the UK and US markets. And right now, Mark thinks there are 6 standout stocks that investors should consider buying. Want to see if Ashtead Group Plc made the list?

See the 6 stocks

I believe for long-term investors, if Glaxo can come anywhere close to replicating AstraZeneca’s R&D success, then the shares are far too cheap. AstraZeneca has a trailing price-to-earnings multiple of around 100, putting into perspective just how cheap Glaxo shares are. 

The shares are cheaper even now, after falling sharply recently. They trade on a P/E of under 12 which to me represents good value compared to other pharma companies and the market more generally.

A cheap share hit hard by the stock market crash

Barratt Developments (LSE: BDEV) could face some short-term pressures from regulatory action concerning leaseholds. It’s unclear as yet what action that could lead to, although the issue itself isn’t particularly new.

More broadly the government has been supporting the sector. In addition to the Stamp Duty cut, Help to Buy is still supporting sales and there are rumours it could be extended even further.

Barratt shares were cheap even before the pandemic because of Brexit and probably because of the possible ending of Help to Buy in 2021. Now the shares are even cheaper as the pandemic closed down the industry earlier this year. So the housebuilders are still playing catchup. They have mostly still to reintroduce their dividends which were cut in response to Covid-19. 

I think the shares are a potentially profitable investment because of their cheapness – they trade on a P/E of 14 – and the potential for the dividend to be reintroduced. Rival Persimmon has already announced the resumption of payments, albeit at a lower rate. Then thirdly, the high levels of cash held by Barratt and its rivals will see them through this period of lower sales.

When I look at GlaxoSmithKline and Barratt Developments, I see two shares that are great value after the stock market crash. To me they are too cheap to ignore, and could make investors money in the future both from share price growth and from dividends.

Should you buy Ashtead Group Plc shares today?

Before you decide, please take a moment to review this first.

Because my colleague Mark Rogers – The Motley Fool UK’s Director of Investing – has released this special report.

It’s called ‘5 Stocks for Trying to Build Wealth After 50’.

And it’s yours, free.

Of course, the decade ahead looks hazardous. What with inflation recently hitting 40-year highs, a ‘cost of living crisis’ and threat of a new Cold War, knowing where to invest has never been trickier.

And yet, despite the UK stock market recently hitting a new all-time high, Mark and his team think many shares still trade at a substantial discount, offering savvy investors plenty of potential opportunities to strike.

That’s why now could be an ideal time to secure this valuable investment research.

Mark’s ‘Foolish’ analysts have scoured the markets low and high.

This special report reveals 5 of his favourite long-term ‘Buys’.

Please, don’t make any big decisions before seeing them.

Claim your free copy now

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Andy Ross owns shares in AstraZeneca and Persimmon. The Motley Fool UK has recommended GlaxoSmithKline. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Young Asian man drinking coffee at home and looking at his phone
Investing Articles

Here’s a dirt-cheap FTSE 100 share to consider before it surges again!

This FTSE 100 share may have doubled in value in 2025. But as Royston Wild explains, it still looks like…

Read more »

Man thinking about artificial intelligence investing algorithms
Investing Articles

Can I buy Cathie Wood’s ARK Innovation ETF for my ISA or SIPP?

The ARK Innovation ETF is a US investment fund. Can the product be bought for an Individual Savings Account or…

Read more »

Little girl helping her Grandad plant tomatoes in a greenhouse in his garden.
Investing Articles

Lloyds shares: here’s the latest price and dividend forecasts

Harvey Jones is thrilled with the total return from his Lloyds shares. Now he examines whether they can keep serving…

Read more »

Investing Articles

Up 50% and 30% in a year! These 2 FTSE 100 dividend shares are behaving like growth stocks

When dividend shares deliver growth as well, investors are in luck. These two FTSE 100 shares are best known for…

Read more »

Middle aged businesswoman using laptop while working from home
Investing Articles

2 stocks every passive income seeker should know about

Dividend shares can be great sources of passive income. Stephen Wright likes the look of two that have fallen out…

Read more »

Mature black woman at home texting on her cell phone while sitting on the couch
Dividend Shares

I asked ChatGPT for the best FTSE 250 stocks for passive income, with these results!

Jon Smith asks his AI friend for advice regarding passive income options, but doesn't agree with all the results that…

Read more »

A handsome mature bald bearded black man in a sunglasses and a fashionable blue or teal costume with a tie is standing in front of a wall made of striped wooden timbers and fastening a suit button
Investing Articles

Want to make a million from penny shares? Here’s 1 way to try

Investors wanting to build up a potential millionaire portfolio with diversified penny shares might want to consider adding this one.

Read more »

Businessman using pen drawing line for increasing arrow from 2024 to 2025
Investing Articles

Want to turn a £20k ISA into a £1m portfolio? Here’s how

Dr James Fox explains the strategy many investors employ when trying to turn their ISA into a life-changing pot of…

Read more »